Wednesday, May 2, 2018
4:00 pm
Gates Annex 22

John D. Roberts Lecture

Perspectives on Nucleotide Research for Antiviral Drugs and Expanding Access
John Martin, Ph.D., CEO, Gilead Sciences, Inc.
Contact Victoria Brennan vicky@caltech.edu at 6151
Add this event to my calendar